Showing codes 70436-147-81 Dicyclomine Hydrochloride — 70436-169-06 Fenofibric Acid

70436-147-81 - Dicyclomine Hydrochloride
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 5 VIAL, SINGLE-DOSE in 1 BOX (70436-147-81) / 2 mL in 1 VIAL, SINGLE-DOSE
Usage type: INTRAMUSCULAR
HTML  TXT

70436-149-55 - Methocarbamol
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 25 VIAL, SINGLE-DOSE in 1 CARTON (70436-149-55) / 10 mL in 1 VIAL, SINGLE-DOSE (70436-149-33)
Usage type: INTRAVENOUS
HTML  TXT

70436-151-57 - Arformoterol Tartrate Inhalation
Firm: Slate Run Pharmaceuticals
Package Description: 30 POUCH in 1 CARTON (70436-151-57) / 1 VIAL in 1 POUCH (70436-151-19) / 2 mL in 1 VIAL
Usage type: RESPIRATORY (INHALATION)
HTML  TXT

70436-151-58 - Arformoterol Tartrate Inhalation
Firm: Slate Run Pharmaceuticals
Package Description: 15 POUCH in 1 CARTON (70436-151-58) / 4 VIAL in 1 POUCH (70436-151-20) / 2 mL in 1 VIAL
Usage type: RESPIRATORY (INHALATION)
HTML  TXT

70436-152-01 - Potassium Chloride
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70436-152-01)
Usage type: ORAL
HTML  TXT

70436-152-03 - Potassium Chloride
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70436-152-03)
Usage type: ORAL
HTML  TXT

70436-153-01 - Potassium Chloride
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70436-153-01)
Usage type: ORAL
HTML  TXT

70436-153-02 - Potassium Chloride
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70436-153-02)
Usage type: ORAL
HTML  TXT

70436-155-41 - Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 118 mL in 1 BOTTLE (70436-155-41)
Usage type: ORAL
HTML  TXT

70436-155-42 - Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 473 mL in 1 BOTTLE (70436-155-42)
Usage type: ORAL
HTML  TXT

70436-156-06 - Cilostazol
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 60 TABLET in 1 BOTTLE (70436-156-06)
Usage type: ORAL
HTML  TXT

70436-157-06 - Cilostazol
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 60 TABLET in 1 BOTTLE (70436-157-06)
Usage type: ORAL
HTML  TXT

70436-160-02 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-02)
Usage type: ORAL
HTML  TXT

70436-160-04 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-04)
Usage type: ORAL
HTML  TXT

70436-160-06 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-06)
Usage type: ORAL
HTML  TXT

70436-161-02 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-02)
Usage type: ORAL
HTML  TXT

70436-161-04 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-04)
Usage type: ORAL
HTML  TXT

70436-161-06 - Tolterodine Tartrate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-06)
Usage type: ORAL
HTML  TXT

70436-162-80 - Eptifibatide
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 10 mL in 1 VIAL (70436-162-80)
Usage type: INTRAVENOUS
HTML  TXT

70436-163-80 - Eptifibatide
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 100 mL in 1 VIAL (70436-163-80)
Usage type: INTRAVENOUS
HTML  TXT

70436-166-01 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-166-01)
Usage type: ORAL
HTML  TXT

70436-166-02 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-166-02)
Usage type: ORAL
HTML  TXT

70436-166-03 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-166-03)
Usage type: ORAL
HTML  TXT

70436-167-01 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-167-01)
Usage type: ORAL
HTML  TXT

70436-167-02 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-167-02)
Usage type: ORAL
HTML  TXT

70436-167-03 - Metoprolol Succinate
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-167-03)
Usage type: ORAL
HTML  TXT

70436-168-03 - Fenofibric Acid
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-168-03)
Usage type: ORAL
HTML  TXT

70436-168-06 - Fenofibric Acid
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-168-06)
Usage type: ORAL
HTML  TXT

70436-169-02 - Fenofibric Acid
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-169-02)
Usage type: ORAL
HTML  TXT

70436-169-03 - Fenofibric Acid
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-169-03)
Usage type: ORAL
HTML  TXT

70436-169-06 - Fenofibric Acid
Firm: Slate Run Pharmaceuticals, LLC
Package Description: 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-169-06)
Usage type: ORAL
HTML  TXT